Technicium Bad news: 1�) be sure, we'll have good results from Japan. I've already spoken to Prof. Rasi about them. 2�) This is the problem: Japan authorities are very slow and complicated: approval within 2004. On the market in 2005 first half. 3�) Shorts: I own MLNM, ARIA, IMGN and other smaller biotechs. Very often shorts have large short interest in these companies. Good news: Sno already told us we are always waiting for Liver Cancer upgrade: hope if management will get Delaware, they will upgrade within the end of the year. Phase 3 Hep C: Sno already told us Ken Sherman was included in FDA Commitee. Guarantee for Zadaxin respect. Our great results will have their fair value. You have got large position at a wonderful average price: within 2006 you'll be very rich.